Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study seeks to determine the safety of three different doses of sc-rAAV2.5IL-1Ra
delivered by intra-articular injection into one knee joint of patients with moderate OA of
the knee.